Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-11-29
1981-11-10
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, 435 4, 435 7, G01N 3348, G01T 100
Patent
active
042998123
ABSTRACT:
In the immunoassay of thyroxine using dried blood samples spotted on filter paper, the assay in this invention is run at a pH of 9.2 to 10.0, preferably at about 9.5, rather than the pH range of about 8.4 to 8.7 generally used in the art. The advantage of this higher pH range is that more accurate results are obtained with neonatal specimens. An additional advantage is that the blank or nonspecific binding is lower for many immunoassay procedures.
REFERENCES:
patent: 3716632 (1973-02-01), Fader et al.
patent: 3745211 (1973-07-01), Brown et al.
patent: 3928553 (1975-12-01), Hollander
Diagnostic Products Corp.
Mueth Joseph E.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Immunoassay of thyroxine in neonates using dried blood samples does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay of thyroxine in neonates using dried blood samples, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay of thyroxine in neonates using dried blood samples will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2362363